SIIA Público

Obras con ISBN:

No hay obras de este autor.

Documentos en revistas:

1.-		Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus (2025)

2.-		Molecular Ancestry Across Allelic Variants of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Mexican-Mestizo DMT2 Patients (2025)

3.-		Impact of SLC22A1 variants rs622342 and rs72552763 on HbA1c and metformin plasmatic concentration levels in patients with type 2 diabetes mellitus (2024)

4.-		Pharmacogenetics: ethnicity, treatment and health in Latin American populations (2023)

5.-		Metformin Pharmacogenetics In DMT2 Mexican-Mestizo Patients And Its Possible Association With Therapeutic Efficacy (2023)

6.-		An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (2022)

7.-		Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital (2021)

8.-		High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations (2020)

9.-		Frequency of CYP2C9 (2, 3 and IVS8-109A>T) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin (2019)

10.-		Carbamazepine adverse drug reactions (2018)

Colaboraciones en Tesis:

No hay tesis de este autor.

Patentes:

No hay patentes de este autor.